| Literature DB >> 28947936 |
Benjamin J Foust1, Michael M Poe2, Nicholas A Lentini1, Chia-Hung Christine Hsiao2, Andrew J Wiemer2,3, David F Wiemer1,4.
Abstract
Studies of aryl phosphonate derivatives of a butyrophilin 3A1 ligand have resulted in identification of a potent stimulant of Vγ9 Vδ2 T cells. This compound, a mixed ester bearing one pivaloyloxymethyl substituent and one 1-naphthyl ester displayed an EC50 of 0.79 nM as a stimulant of T cell proliferation, and a 9.0 nM EC50 in an assay designed to measure interferon gamma production. In both assays, this is the most potent butyrophilin ligand prodrug yet reported, and thus it should be a valuable tool for studies of T cell function. Furthermore, mixed aryl/acyloxyalkyl esters may represent a new class of phosphonate prodrugs with high efficacy.Entities:
Keywords: Aryl phosphonates; BTN3A1; butyrophilin; ligand; phosphoantigen; prodrug
Year: 2017 PMID: 28947936 PMCID: PMC5601366 DOI: 10.1021/acsmedchemlett.7b00245
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345